Agios Pharmaceuticals Inc
SWB:8AP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Agios Pharmaceuticals Inc
SWB:8AP
|
US |
|
Kinarus Therapeutics Holding AG
SIX:CURN
|
CH |
|
P
|
PTC Therapeutics Inc
XMUN:BH3
|
US |
|
M
|
McCormick & Company Inc
DUS:MCX
|
US |
|
Churchill Downs Inc
NASDAQ:CHDN
|
US |
|
C
|
Coloray International Investment Co Ltd
KOSDAQ:900310
|
HK |
|
O
|
OCI NV
OTC:OCINF
|
NL |
|
N
|
National Beverage Corp
F:20V
|
US |
|
P
|
Philip Morris International Inc
XMUN:4I1
|
US |
|
B
|
Borgestad ASA
OSE:BOR
|
NO |
|
P
|
Pearson PLC
F:PES
|
UK |
|
G
|
GN Store Nord A/S
XMUN:GNN
|
DK |
|
S
|
SPVI PCL
SET:SPVI
|
TH |
|
Bango PLC
F:B1O
|
UK |
|
H
|
Hanover Insurance Group Inc
F:AF4
|
US |
|
L
|
Leef Brands Inc
CNSX:LEEF
|
CA |
|
T
|
T S Flour Mill PCL
SET:TMILL
|
TH |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
DUS:BOY
|
ES |
|
A
|
Asahi Kasei Corp
XMUN:ASAA
|
JP |
|
D'Ieteren Group SA
XBRU:DIE
|
BE |
|
Impax Asset Management Group PLC
LSE:IPX
|
UK |
|
T
|
Terex Corp
XMUN:TXG
|
US |
|
M
|
Mettler-toledo International Inc
XMUN:MTO
|
US |
|
Ggtoor Inc
OTC:GTOR
|
US |
Shareholder Yield
Current shareholder yield for 
8AP is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
8AP Price
Agios Pharmaceuticals Inc
| Average Annual Return | 3.45% |
| Standard Deviation of Annual Returns | 34.77% |
| Max Drawdown | -65% |
| Market Capitalization | 1.9B EUR |
| Shares Outstanding | 32 927 095 |
| Percentage of Shares Shorted |
N/A
|
